Increased atrial effectiveness of flecainide conferred by altered biophysical properties of sodium channels-Reference-Cited by-同舟云学术

Increased atrial effectiveness of flecainide conferred by altered biophysical properties of sodium channels

Published:2022-05 Issue: Volume:166 Page:23-35
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

O' Brien Sian,Holmes Andrew P.,Johnson Daniel M.,Kabir S. Nashitha,O' Shea Christopher,O' Reilly Molly,Avezzu Adelisa,Reyat Jasmeet S.,Hall Amelia W.,Apicella Clara,Ellinor Patrick T.,Niederer Steven,Tucker Nathan R.,Fabritz Larissa,Kirchhof Paulus,Pavlovic Davor

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference62 articles.

1. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060;Krijthe;Eur. Heart J.,2013

2. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence;Miyasaka;Circulation,2006

3. Mortality and morbidity in patients receiving encainide, flecainide, or placebo;Echt;N. Engl. J. Med.,1991

4. Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial;Kirchhof;Lancet,2012

5. Improving outcomes in patients with atrial fibrillation: rationale and design of the early treatment of atrial fibrillation for stroke prevention trial;Kirchhof;Am. Heart J.,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of novel open-source software for cardiac optical mapping;Journal of Molecular and Cellular Cardiology Plus;2024-06

2. Kir2.1-NaV1.5 channelosome and its role in arrhythmias in inheritable cardiac diseases;Heart Rhythm;2024-05

3. The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3;Cardiovascular Research;2024-01-23

4. Optical mapping and optogenetics in cardiac electrophysiology research and therapy: a state-of-the-art review;Europace;2024-01-16

5. Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes;Basic Research in Cardiology;2024-01-03